InCerebro ^Company

InCerebro is a pharmaceutical research and development company that specializes in drug discovery using advanced technologies such as modeling, AI, and imagination. Their state-of-the-art technology platform, MIND, allows for in silico target modeling and drug discovery. InCerebro's achievements include solving and studying the structure of small proteins using X-ray crystallography and developing platforms for preparing complex and topology, solvating globular proteins, orienting bilayer/micelle to protein, and solvating membrane-receptors. They also have a Protein-Protein Interaction (PPI) AIMD platform for studying protein-protein interactions.